Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Avelumab as Single Agent in Metastatic or Locally Advanced Urothelial Cancer in Patients Unfit for Cisplatin

NCT03891238 is registered in ClinicalTrials.gov with Consorzio Oncotech as lead sponsor.

NCT NCT03891238
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03891238 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Avelumab as Single Agent in Metastatic or Locally Advanced Urothelial Cancer in Patients Unfit for Cisplatin
Lead sponsor
Consorzio Oncotech
Phase
Phase 2
Overall status
Completed
Start date
February 6, 2019
Completion date
September 15, 2021
Enrollment
67 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic or locally advanced pd-l1 positive urothelial cancer